F Xu1, H Zhang, Y Su, J Kong, H Yu, B Qian. 1. Department of Epidemiology and Biostatistics, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Tianjin, 300060, People's Republic of China.
Abstract
BACKGROUND: Lung cancer in never smokers presents predominately as adenocarcinoma and in females. MicroRNA-183 (miR-183) has various expression patterns in types of human cancers. In the present study, we evaluated the expression of miR-183-3p in female lung adenocarcinoma and adjacent noncancerous tissues and explored its relationship with clinicopathological characteristics and prognosis. METHODS: In the present study, a hundred female nonsmoking patients who were newly diagnosed and histologically confirmed as lung adenocarcinoma at Tianjin Medical University Cancer Hospital were included. miR-183-3p expression of surgically removed NSCLC tissues and their corresponding normal lung tissues was measured by qRT-PCR assay. Associations of miR-183-3p expression with clinicopathological features were determined using the Student's t test. Log-rank test, and Cox proportional hazards model were used for survival analysis. RESULTS: At first, miR-183-3p was up-regulated in lung cancer tissues when compared with the corresponding noncancerous lung tissues. Moreover, the expression of miR-183-3p in tumor tissue was found to be associated with lymph node metastasis (P = 0.043), clinical stage (P = 0.015), and EGFR mutation (P = 0.003). At last, high miR-183-3p expression was also associated with both poor overall survival and progression-free survival of women with lung adenocarcinoma (P = 0.005 and P = 0.010, respectively). CONCLUSION: This study suggested that miR-183-3p expression might be involved in lung cancer pathogenesis and progression, and could be used as a potential prognostic biomarker of female lung adenocarcinoma.
BACKGROUND:Lung cancer in never smokers presents predominately as adenocarcinoma and in females. MicroRNA-183 (miR-183) has various expression patterns in types of humancancers. In the present study, we evaluated the expression of miR-183-3p in female lung adenocarcinoma and adjacent noncancerous tissues and explored its relationship with clinicopathological characteristics and prognosis. METHODS: In the present study, a hundred female nonsmoking patients who were newly diagnosed and histologically confirmed as lung adenocarcinoma at Tianjin Medical University Cancer Hospital were included. miR-183-3p expression of surgically removed NSCLC tissues and their corresponding normal lung tissues was measured by qRT-PCR assay. Associations of miR-183-3p expression with clinicopathological features were determined using the Student's t test. Log-rank test, and Cox proportional hazards model were used for survival analysis. RESULTS: At first, miR-183-3p was up-regulated in lung cancer tissues when compared with the corresponding noncancerous lung tissues. Moreover, the expression of miR-183-3p in tumor tissue was found to be associated with lymph node metastasis (P = 0.043), clinical stage (P = 0.015), and EGFR mutation (P = 0.003). At last, high miR-183-3p expression was also associated with both poor overall survival and progression-free survival of women with lung adenocarcinoma (P = 0.005 and P = 0.010, respectively). CONCLUSION: This study suggested that miR-183-3p expression might be involved in lung cancer pathogenesis and progression, and could be used as a potential prognostic biomarker of female lung adenocarcinoma.
Authors: Stephen S Myatt; Jun Wang; Lara J Monteiro; Mark Christian; Ka-Kei Ho; Luca Fusi; Roberto E Dina; Jan J Brosens; Sadaf Ghaem-Maghami; Eric W-F Lam Journal: Cancer Res Date: 2009-12-22 Impact factor: 12.701
Authors: Linka Xie; Alexey Ushmorov; Frank Leithäuser; Hanfeng Guan; Christian Steidl; Johanna Färbinger; Christin Pelzer; Marion J Vogel; Harald J Maier; Randy D Gascoyne; Peter Möller; Thomas Wirth Journal: Blood Date: 2012-02-17 Impact factor: 22.113
Authors: James A McCubrey; Linda S Steelman; C Ruth Kempf; William H Chappell; Stephen L Abrams; Franca Stivala; Graziella Malaponte; Ferdinando Nicoletti; Massimo Libra; Jörg Bäsecke; Danijela Maksimovic-Ivanic; Sanja Mijatovic; Giuseppe Montalto; Melchiorre Cervello; Lucio Cocco; Alberto M Martelli Journal: J Cell Physiol Date: 2011-11 Impact factor: 6.384
Authors: Liang Chen; Youhuai Li; Yebo Fu; Jin Peng; Meng-Hsuan Mo; Michael Stamatakos; Christine B Teal; Rachel F Brem; Alexander Stojadinovic; Michael Grinkemeyer; Timothy A McCaffrey; Yan-gao Man; Sidney W Fu Journal: PLoS One Date: 2013-01-23 Impact factor: 3.240
Authors: Ivan A Zaporozhchenko; Evgeny S Morozkin; Tatyana E Skvortsova; Anastasia A Ponomaryova; Elena Yu Rykova; Nadezhda V Cherdyntseva; Evgeny S Polovnikov; Oksana A Pashkovskaya; Evgeny A Pokushalov; Valentin V Vlassov; Pavel P Laktionov Journal: PLoS One Date: 2016-10-21 Impact factor: 3.240